Cooperative Agreement U01DA063213
- The University of California, San Diego (UCSD) was awarded a $4,874,620 Cooperative Agreement from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The funding will support a binational cohort study to prospectively examine the intersection of substance use, HIV, and associated comorbidities among people who inject drugs in the San Diego region. Key objectives include characterizing trends and predictors of established and emerging...
- The University of California, San Diego (UCSD) was awarded a $2,223,769 Project Grant from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), with an award date of April 15, 2025 and an ultimate completion date of January 31, 2030. The grant will fund a comprehensive investigation to uncover the mechanistic intersection through which HIV and opioids heighten inflammation, with the goal of offering insights for targeted interventions...
- This federal Project Grant award of $200,446.00 was provided by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, under their Drug Use and Addiction Research Programs (CFDA 93.279). The grant supports a mixed-methods study to examine the impact of novel housing programs, such as temporary shelters and displacement policies, on overdose outcomes among unhoused individuals who use drugs in San Diego, California. The research will involve a longitudinal...
- This Project Grant award of $1,573,958 from the National Institute on Drug Abuse (NIDA), part of the Drug Use and Addiction Research Programs (CFDA 93.279), is focused on identifying individuals who are viremic and/or have substance use disorder (SUD) to engage them for early intervention. The project will implement routine SUD screening using the NIDA Quick Screen and a social network intervention to find individuals who are viremic, have SUD, or both, and link them to harm reduction and HIV...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $715,238 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of California, San Diego (UCSD) to conduct a "Multivariate Genome-Wide Association Analysis of Opioid-Related Traits in Half a Million Diverse Individuals." The project aims to improve understanding of the genetic basis of opioid use disorder (OUD) and related pre-addiction...
- The U.S. National Institutes of Health (NIH) awarded a Cooperative Agreement under the Trans-NIH Research Support program (CFDA 93.310) to Wake Forest University Health Sciences (WFUHS) in the amount of $1,098,513 beginning September 1, 2025. The overarching goal of the "CASCADE" (Carolina Addiction Science Coalition for Accelerating Discovery and Engagement) project is to investigate the impacts of drug use patterns and addiction treatment on the HIV prevention and care cascade in the...
- The University of California, San Diego (UCSD) was awarded a $2,911,005 Project Grant from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) to conduct a retrospective study evaluating the impact of public health activities related to the HIV care continuum in New York City. The project, titled "CHROME: Continuum of HIV Response through Observational Molecular Epidemiology", aims to determine if individuals without...
- This Cooperative Agreement award is funded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, under the Drug Use and Addiction Research Programs (CFDA 93.279). The $7,372,834 award to Florida International University supports a cohort study titled "Cohort Studies of HIV/AIDS and Substance Use in Miami" that will expand the existing Miami Adult Studies on HIV (MASH) cohort to 1,879 participants to increase representation of women. The study aims...
- The University of California, Irvine (UCI) was awarded a $558,085 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) on July 15, 2025. This grant, titled "TEAM SCIENCE FOR MULTISCALE DATA MINING AND FUNCTIONAL VALIDATION OF SINGLE-CELL OPIOID RESPONSES IN THE CONTEXT OF HIV", aims to unravel the interplay between the opioid epidemic and HIV by generating large-scale molecular profiling data at single-nuclei...
- This federal Project Grant award for $896,804, provided by the National Institute on Drug Abuse (NIDA) through the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop a cost-based epidemiological planning tool to address the combined HIV, HCV, and opioid use disorder epidemics. The key products and services to be delivered under this award are: 1) Development of an interactive, web-based dashboard that can assist policymakers in planning an effective multi-pronged response to...
The University of California, San Diego (UCSD) was awarded a $2,078,061 Cooperative Agreement by the National Institute on Drug Abuse (CFDA 93.279 Drug Use and Addiction Research Programs) to conduct the "Responding to the Increase in Substance Use, HIV, HCV, and Overdose in New England" (RISE-NE) cohort study. This five-year project aims to systematically examine evolving trends in substance use, HIV, hepatitis C, and overdose in New England. The study will recruit a cohort of 1,200 people who use drugs, including 15% living with HIV, and conduct biannual behavioral assessments and biospecimen collection to inform the scale-up of evidence-based prevention and treatment services in the region. The award began on August 15, 2025 and is scheduled for completion on May 31, 2030.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 8/20/25 | ||
| Not listed | $2.1m | 8/8/25 |